Genmab — December 2012
-
Samir
-
Hexabody
-
er heller ikke phd
-
clustering - det kender jeg godt fra IT
-
der virker det meget dårligt
-
jeg ønsker ikke at forstå det
-
de kan clusterfucke noget og det er milliarder værd
-
(min konklusion)
-
Så kommer det interessante spørgsmål: er det en ADC killer?
-
det er at supercharge et antistof
-
så derfor er det jo interessant
-
hvis de kan udkonkurrere ADC
-
no doubt that partners will jump into the Hexabody development
-
så er der brand
-
i det mindste er det ikke en hund
-
kom nu ud af bygningen. man dør ikke i en q&a
-
Peter Wellford, vil også dø for en god analyse til kunderne
-
Godt spørgsmål
-
hvis duobody partnerne vil have hexabody så skal de bløde penge
-
thank you !
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind